Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Blood|October 6, 2001
Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDST de Witte, S Suciu, G Verhoef, et al.
Blood|January 15, 1997
Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypesA Venditti, G Del Poeta, F Buccisano, et al.
Leukemia|May 24, 2003
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocolsF Mandelli, R Latagliata, G Avvisati, et al.
Leukemia|August 26, 2006
Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trialU Jehn, S Suciu, X Thomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trialsL Pagano, A Pulsoni, M Vignetti, et al.
Bone Marrow Transplantation|November 11, 1999
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methodsA Venditti, A Battaglia, G Del Poeta, et al.
Bone Marrow Transplantation|November 18, 2014
High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMTM Hengeveld, S Suciu, Y Chelgoum, et al.
Annals of Hematology|April 15, 2015
Minimal residual disease negativity in elderly patients with acute myeloid leukemia may indicate different postremission strategies than in younger patientsF Buccisano, L Maurillo, A Piciocchi, et al.
Leukemia|May 3, 2016
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapyL Cicconi, M Divona, C Ciardi, et al.
Pageof 15